vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and CF BANKSHARES INC. (CFBK). Click either name above to swap in a different company.
CF BANKSHARES INC. is the larger business by last-quarter revenue ($15.7M vs $8.1M, roughly 1.9× Arcellx, Inc.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -766.0%, a 806.1% gap on every dollar of revenue. On growth, CF BANKSHARES INC. posted the faster year-over-year revenue change (12.6% vs -79.3%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $-63.9M). Over the past eight quarters, CF BANKSHARES INC.'s revenue compounded faster (13.7% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
ACLX vs CFBK — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $15.7M |
| Net Profit | $-62.3M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | -847.6% | 43.4% |
| Net Margin | -766.0% | 40.0% |
| Revenue YoY | -79.3% | 12.6% |
| Net Profit YoY | -765.1% | 29.9% |
| EPS (diluted) | $-1.13 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $15.7M | ||
| Q3 25 | — | $15.5M | ||
| Q2 25 | — | $15.6M | ||
| Q1 25 | $8.1M | $14.1M | ||
| Q4 24 | $15.3M | $14.0M | ||
| Q3 24 | $26.0M | $13.1M | ||
| Q2 24 | $27.4M | $12.6M | ||
| Q1 24 | $39.3M | $12.2M |
| Q4 25 | — | $5.7M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $5.0M | ||
| Q1 25 | $-62.3M | $4.4M | ||
| Q4 24 | $-47.1M | $4.4M | ||
| Q3 24 | $-25.9M | $4.2M | ||
| Q2 24 | $-27.2M | $1.7M | ||
| Q1 24 | $-7.2M | $3.1M |
| Q4 25 | — | 43.4% | ||
| Q3 25 | — | 17.5% | ||
| Q2 25 | — | 41.1% | ||
| Q1 25 | -847.6% | 39.5% | ||
| Q4 24 | -348.2% | 36.9% | ||
| Q3 24 | -129.1% | 40.4% | ||
| Q2 24 | -127.8% | 15.4% | ||
| Q1 24 | -40.3% | 30.9% |
| Q4 25 | — | 40.0% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 32.3% | ||
| Q1 25 | -766.0% | 31.4% | ||
| Q4 24 | -308.4% | 35.2% | ||
| Q3 24 | -99.4% | 32.2% | ||
| Q2 24 | -99.3% | 13.5% | ||
| Q1 24 | -18.3% | 25.2% |
| Q4 25 | — | $0.88 | ||
| Q3 25 | — | $0.36 | ||
| Q2 25 | — | $0.77 | ||
| Q1 25 | $-1.13 | $0.68 | ||
| Q4 24 | $-0.87 | $0.68 | ||
| Q3 24 | $-0.48 | $0.65 | ||
| Q2 24 | $-0.51 | $0.26 | ||
| Q1 24 | $-0.14 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $259.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $184.4M |
| Total Assets | $648.1M | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $259.0M | ||
| Q3 25 | — | $272.4M | ||
| Q2 25 | — | $275.7M | ||
| Q1 25 | $543.3M | $241.0M | ||
| Q4 24 | $587.4M | $235.3M | ||
| Q3 24 | $574.3M | $233.5M | ||
| Q2 24 | $516.7M | $241.8M | ||
| Q1 24 | $573.9M | $236.9M |
| Q4 25 | — | $184.4M | ||
| Q3 25 | — | $179.3M | ||
| Q2 25 | — | $177.0M | ||
| Q1 25 | $416.9M | $172.7M | ||
| Q4 24 | $454.8M | $168.4M | ||
| Q3 24 | $483.0M | $164.0M | ||
| Q2 24 | $487.2M | $159.6M | ||
| Q1 24 | $496.6M | $158.0M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | $648.1M | $2.1B | ||
| Q4 24 | $711.3M | $2.1B | ||
| Q3 24 | $764.9M | $2.1B | ||
| Q2 24 | $734.3M | $2.0B | ||
| Q1 24 | $779.7M | $2.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $18.7M |
| Free Cash FlowOCF − Capex | $-63.9M | $18.2M |
| FCF MarginFCF / Revenue | -786.4% | 115.6% |
| Capex IntensityCapex / Revenue | 9.6% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 3.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $33.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $18.7M | ||
| Q3 25 | — | $5.5M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | $-63.1M | $2.2M | ||
| Q4 24 | $-46.0M | $14.2M | ||
| Q3 24 | $30.7M | $-1.3M | ||
| Q2 24 | $-36.2M | $4.0M | ||
| Q1 24 | $-31.9M | $-1.2M |
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $5.2M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | $-63.9M | $2.2M | ||
| Q4 24 | $-47.5M | $13.9M | ||
| Q3 24 | $28.4M | $-1.3M | ||
| Q2 24 | $-39.5M | $4.0M | ||
| Q1 24 | $-38.3M | $-1.2M |
| Q4 25 | — | 115.6% | ||
| Q3 25 | — | 33.6% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | -786.4% | 15.2% | ||
| Q4 24 | -311.3% | 99.6% | ||
| Q3 24 | 109.2% | -9.9% | ||
| Q2 24 | -144.1% | 31.6% | ||
| Q1 24 | -97.7% | -9.5% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | 9.6% | 0.4% | ||
| Q4 24 | 9.8% | 1.9% | ||
| Q3 24 | 8.8% | 0.2% | ||
| Q2 24 | 11.7% | 0.1% | ||
| Q1 24 | 16.4% | 0.0% |
| Q4 25 | — | 3.26× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 3.21× | ||
| Q3 24 | — | -0.30× | ||
| Q2 24 | — | 2.35× | ||
| Q1 24 | — | -0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
